THE GLOBAL MEDICAL AESTHETICS MARKET SIZE WAS VALUED AT USD 21.05 BILLION IN 2021 AND IS EXPECTED TO REACH USD 45.52 BILLION BY 2027, GROWING AT A CAGR OF 13.71% DURING THE FORECAST PERIOD

The Global Medical Aesthetics Market Size, Share, Growth Forecast by: 

  • Procedures: Minimally Invasive and Non-Invasive
  • Product: Body Contouring Devices, Laser & Energy Based Devices, Cosmetic Implants, Derma Filler & Neuromodulators, Microneedling & Chemical Peels, Microdermabrasion, And Other
  • Application: Body Contouring & Cellulite Reduction, Skin Tightening & Skin Lighteners, Facial Aesthetic, Breast Augmentation, And Other
  • End User: Hospital & Skin Clinics, Medical Spa & Beauty Centres, And Homecare
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

354 Pages

icon-table

177 Tables

icon-chart

154 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

48 Companies

icon-market

5 Market Segment

MEDICAL AESTHETICS MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 45.52 Billion
Market Size (2021) USD 21.05 Billion
CAGR (2022-2028) 13.71%
Base Year 2021
Forecast Year 2022-2027
Market Segments Procedures, Product, Application, End User, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORS AbbVie (Allergan), Bausch Health Companies, Candela, Cutera, Cynosure, EL.En. S.p.A., Galderma, Johnson & Johnson, Lumenis, Merz Pharma, Sientra, Sinclair, and Sisram Medical

MARKET INSIGHTS

The global medical aesthetics market is growing with a CAGR of 13.71% from 2022 to 2027 and is projected to reach USD 45.52 billion by 2027 from USD 21 billion in 2021. The global medical aesthetics market trends include consumers seeking aesthetic procedures starting at a younger age, an uptick in men seeking cosmetic enhancement procedures, and an increasing preference for non-invasive cosmetic procedures instead of cosmetic surgery. The market is witnessing the launch of many advanced and innovative devices and products from global, regional, and local vendors. Facelifts, liposuction, botox & neuromodulators, skin resurfacing, and intense pulse light procedures are witnessing high demand from various age groups.

Medical aesthetics treatment focuses on treating and improving the appearance of the patient skin & body. Medical aesthetics treatments are not as aggressive as surgical interventions; they include minimally invasive and non-invasive surgical procedures that enhance the body shape, skin texture, and other benefits. It required high skills, knowledge, and training in human anatomy and physiology. The global medical aesthetics industry has changed in the past few years, with the overall demand for cosmetic treatments trending in a single direction; on another side despite the barriers and restrictions on cosmetic procedures significantly imposed by the COVID-19 pandemic, there was still a healthy rise of 3% from 2019. This reveals that the preference for improving appearance is strong, and there are enormous opportunities for the medical aesthetics market in the coming years.

New Medical Aesthetics Launched in the Medical Aesthetics Market

  • In 2022, newly launched treatment such as Ellacor dermal micro-coring is becoming more popular for lines and laxity.
  • A newly developed treatment RHA Redensity is used for lip lines. RHA Redensity gets approval for the correction of moderate and severe lip lines.
  • In 2022, a new thread lift, “APTOS, " was launched. The Aptos PLLA/PCL treads are developed from a novel blend of polymer material. These threads have good tissue gripping strengths with longer-lasting results.
  • The new glow-boosting injectable “Volite” is more akin to that of a laser for enhancing skin quality, tone, and texture.
  • The newly developed Sculptra for cellulite is collagen stimulating injectables indication used off-label for many years for the augmentation of the buttocks wrap up with clinical trials expected in 2022.
  • The breast-enhancing implant A Cleavage will be available for patient use in 2022.

In the global medical aesthetics market, platelet-rich plasma is a highly popular cosmetic injectable medical treatment that helps nurture the skin appearance in aged people due to the ability to naturally rejuvenate the skin and repair and treat the aging sign by using the patient’s platelet-rich blood cells. This procedure has become more trending in recent years. In addition, the safety and rapid result ability deliver significant market growth opportunities for key players. Several factors play a vital role in the rising demand for PRP like in cosmetic procedures, PRP is applicable for hair loss and skin rejuvenation. In hair loss, PRP is commonly used for treating male pattern baldness for both purposes, such as hair loss prevention and promoting new hair growth. Dermatologists and plastic surgeons highly recommend the PRP procedure in high-income countries to improve skin appearance and overall health.

The advancement in medical aesthetics procedures will expect to achieve significant market growth. The medical aesthetics market is overgrowing with aesthetic dermatology sectors, including innovations in botanical blends in hair care, skincare, and others. The procedures, methodologies, and systems applied for dermatology procedures in the past were completely different from recent years. The significant changes in dermatology care and advancement in technology in skincare and medical aesthetics paved the direction for innumerable procedures that reduced the side effects. Laser applications are highly adopted for treating gentle vascular birthmarks, haemangioma, and other skin issues.

MARKET TRENDS & OPPORTUNITIES

The Surge in Demand for Minimally Invasive & Non-invasive Aesthetic Procedures
The demand for minimally invasive procedures increased significantly in recent years across all demographics. In addition, non-invasive treatments are a more accessible entry point in the medical aesthetic market for men and young people who are highly curious about their appearance and well-known about medical aesthetics. It indicated that the non-invasive procedures are a good fit for many consumers due to their affordable cost, low downtime, and lower risk.

Increasing Per Capita Expenditure & Acceptance of Aesthetic Procedure
Over the decade, the rising awareness about medical aesthetic solutions and increasing expenditure on personal care/cosmeceutical significantly induced medical aesthetics market growth. In 2022, the Aesthetic Society report revealed that the increasing expense for aesthetic solutions had given high market growth in recent years. People spent approximately USD 9.3 billion on aesthetic procedures in 2020. Of that, around USD 3 billion was registered for non-invasive treatment and USD 6 billion for invasive treatments. From 2019 to 2020, the expenditure for aesthetic procedures increased to almost 80%. In 2019, approximately USD 8.2 billion was spent on aesthetic procedures. This significant growth shows the rising expenditure and awareness about medical aesthetic procedures.

The youth and aging population are the primary users of medical aesthetics treatment. These treatments to combat aging have emerged from anti-aging creams to approved cosmetic procedures. Currently, more and more young population are turning to cosmetic and aesthetic procedures to prevent their bodies from aging.

Medical Tourism Contributing to Surge in Medical Aesthetic Procedures
Medical tourism is expanding globally, with patients seeking cosmetic surgery abroad. The changes caused by the globalization of medical services, the shift of lifestyle with displaying a healthy lifestyle, attention to the figure, and well-being associated with external appearance, combined with the willingness to travel, have given rise to a new segment of health tourism, that is aesthetic medicine tourism.

SEGMENTATION ANALYSIS

INSIGHTS BY PROCEDURE
The medical aesthetics market by procedure type includes non-invasive and minimally invasive cosmetic procedures aimed at improving the physical appearance and satisfaction of the target patient. The minimally invasive procedure segment accounts for 57.14% highest market share, and non-invasive procedures account for 42.86% market share in 2021. Minimally invasive and non-invasive aesthetic procedures are trending and widely accepted globally, owing to fewer surgical interventions, low downtime, less pain, and high safety/efficacy.

INSIGHTS BY PRODUCT
The global medical aesthetics market by product type is dominated by the body contouring devices segment and accounts for a 27.38% market share. The market is by product type segments into body contouring devices, laser & energy-based devices, cosmetic implants, derma fillers & neuromodulators, micro-needling & chemical peels, microdermabrasion, and others (thread lift and skin lighteners). The increasing number of minimally invasive medical aesthetic procedures drive the segmental growth to reduce fat and body shaping and accelerate the higher segmental growth in 2021. Behind body countering devices, lased and energy-based devices accounted for a 21.86% market share and indicated rapid industry growth.

INSIGHTS BY APPLICATION
Body contouring & cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, and others are the key segments by application in the global medical aesthetic market. In which body contouring & cellulite reduction application segment accounted for a 30.58% market share. The increasing demand for fat reduction, cellulite reduction, and liposuction procedures drives segmental growth. Skin tighteners and resurfacing are also becoming more popular in recent years, which is expected to achieve significant growth in the upcoming time.

INSIGHTS BY END-USERS
The global medical aesthetics market is segmented into hospitals & skin clinics, medical spas & beauty centers, and homecare on end-users basics. In 2021, hospitals and skin clinics accounted for a 55.24% market share, dominating the other segments. The increasing demand for minimally invasive and non-invasive procedures and rising awareness drive the high hospital visits and fuel segmental growth. Also, medical aesthetic treatments show easily accessible and deliverable advancements in hospitals and clinics, which drives segmental growth.

GEOGRAPHICAL ANALYSIS

North America dominates the global medical aesthetics market and is expected to grow with a CAGR of 12.52% during the forecast period. The factors that propel the market growth in the region are the higher expenditure on medical aesthetic procedures, well-established healthcare infrastructure, and access to medical aesthetic procedures. In North America, the U.S. is a well-developed country that solely drives significant industry growth. In the U.S., liposuction, breast augmentation, and tummy tuck medical aesthetic procedures are in high demand.

Among all regions, APAC is expected to grow faster, with a CAGR of around 15% during the forecast period. The rising aging population, the increasing acceptance and demand for cosmetic surgeries, and expenditure on medical aesthetic procedures show significant market growth opportunities in the region. In addition, the growing access to medical aesthetic procedures in Japan, China, India, South Korea, and Australia shows significant improvement.

VENDOR LANDSCAPE

The global medical aesthetics market is highly competitive and dynamic, with many international, regional, and local vendors offering a diverse range of medical aesthetic procedure products, treatments, and devices to the end-user. Global players such as AbbVie (Allergan), Sisram Medical, Cutera Inc., Lumenis Inc., Bausch & Lomb, and El En Spa are some of the primary industry players that consistently influence the competition in the industry.

Based on geography, most industry players are headquartered in the U.S., Japan, European Region, and APAC region. One of the U.S.-based companies, AbbVie leading industry player in the medical aesthetics market with a broad spectrum of innovative and advanced solutions for solving serious health issues. In 2021, AbbVie acquired Allergan, the leading company in the medical aesthetics market. This acquisition creates a new product portfolio in AbbVie's product portfolio. Also, the highly demanded and popular Botox comes under the AbbVie product category. Botox individually influences high competition in the industry.

Frequently Asked Questions

What is the size of the global medical aesthetics market?

The global medical aesthetics market size was valued at USD 21.05 billion in 2021 and is expected to reach USD 45.52 billion by 2027.

What is the global medical aesthetics market growth?

The global medical aesthetics market share is expected to grow at a CAGR of 13.71% from 2022 to 2027.

What are the trends in the global medical aesthetics market?

Rapid progress in the application of platelet-rich plasma (PRP) in medical aesthetics, advancements in medical aesthetics, and new medical aesthetic treatments & developments are some significant trends in the global medical aesthetics market.

Who are the key players in the global medical aesthetics market?

AbbVie (Allergan), Bausch Health Companies, Candela, Cutera, Cynosure, EL.En. S.p.A., Galderma, Johnson & Johnson, Lumenis, Merz Pharma, Sientra, Sinclair, and Sisram Medical are the leading global medical aesthetics market companies.

Which region will dominate the global medical aesthetics market share?

North America dominates the global medical aesthetics market and accounts for a revenue share of 45%. The region leads due to its high capability of expenditure for aesthetic procedures and increased awareness among the people propelling the region's market growth.

Download Free Sample

The global medical aesthetics market is expected to grow at a CAGR of approximately 13.71% from 2022 to 2027.

The following factors are likely to contribute to the growth of the global medical aesthetics market during the forecast period:

  • Better Access for Cosmetic Surgeries by Medical Tourism
  • Increasing Awareness & Expenditure on Medical Aesthetic & Cosmetic Solutions
  • Increasing Demand for Minimally Invasive & Non-invasive Surgeries
  • Ageing Demographics & Increasing Focus on Improving Appearance & Youthfulness

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the global medical aesthetic market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  • AbbVie (Allergan)
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Bausch Health Companies
  • Candela
  • Cutera
  • Cynosure
  • EL.En. S.p.A.
  • Galderma
  • Johnson & Johnson
  • Lumenis
  • Merz Pharma
  • Sientra
  • Sinclair
  • Sisram Medical

Other Prominent Vendors

  • Aerolase
    • Business Overview
    • Product Offerings
  • Aesthetics Biomedical
  • Asclepion Laser Technologies
  • Astanza Laser
  • Beijing Sanhe Beauty S & T Co.
  • Beijing ADSS Development
  • Biolitec
  • Biotec Italia
  • BISON Medical
  • Bluecore Company
  • Brera Medical Technologies S.R.L.
  • BTL Aesthetics
  • Cartessa Aesthetics
  • Dominion Aesthetic Technologies
  • Erchonia
  • ENDYMED
  • F Care Systems
  • Gigaalaser
  • GSD - Global Skin Dermatologist
  • InMode Aesthetic Solutions
  • Leaflife Technology
  • LINLINE Medical Systems
  • Lutronic
  • Lynton Lasers
  • MedArt ApS
  • Microaire Surgical Instruments
  • Medytox
  • Meyer-Haake
  • PhotoMedex
  • Revance Aesthetics
  • Sciton
  • ThermiGen
  • Venus Concept
  • Wavemed
  • Zimmer MedizinSysteme

Segmentation by Procedures

  • Minimally Invasive
  • Non-Invasive

Segmentation by Product

  • Body Contouring Devices
  • Laser & Energy Based Devices
  • Cosmetic Implants
  • Derma Filler & Neuromodulators
  • Microneedling & Chemical Peels
  • Microdermabrasion
  • Other

Segmentation by Application

  • Body Contouring & Cellulite Reduction
  • Skin Tightening & Skin Lighteners
  • Facial Aesthetic
  • Breast Augmentation
  • Others

Segmentation by End-Users

  • Hospital & Skin Clinics
  • Medical Spa & Beauty Centres
  • Homecare

Segmentation by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS

4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW

8 PREMIUM INSIGHTS
8.1 OVERVIEW
8.1.1 MEDICAL AESTHETICS MARKET SCENARIO
8.1.2 MEDICAL AESTHETICS MARKET SEGMENTATION

9 MARKET OPPORTUNITIES & TRENDS
9.1 APPLICATION OF PLATELET-RICH PLASMA (PRP) IN MEDICAL AESTHETICS
9.2 ADVANCES IN MEDICAL AESTHETICS
9.3 LAUNCH OF NEW MEDICAL AESTHETIC TREATMENTS
10 MARKET GROWTH ENABLERS
10.1 BETTER ACCESS TO COSMETIC SURGERIES THROUGH MEDICAL TOURISM
10.2 INCREASING EXPENDITURE ON MEDICAL AESTHETIC PROCEDURES
10.3 RISE IN DEMAND FOR MINIMALLY INVASIVE & NON-INVASIVE SURGERIES
10.4 AGING DEMOGRAPHIC COHORTS & INCREASING FOCUS ON IMPROVING APPEARANCE

11 MARKET RESTRAINTS
11.1 SIDE EFFECTS ASSOCIATED WITH MEDICAL AESTHETIC TREATMENTS
11.2 HIGH COSTS ASSOCIATED WITH MEDICAL AESTHETIC TREATMENTS

12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 GEOGRAPHY INSIGHTS
12.2.2 PROCEDURE INSIGHTS
12.2.3 PRODUCT INSIGHTS
12.2.4 APPLICATION INSIGHTS
12.2.5 END-USER INSIGHTS
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY

13 PROCEDURES
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 MINIMALLY INVASIVE MEDICAL AESTHETICS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 NON-INVASIVE MEDICAL AESTHETICS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY

14 PRODUCT
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BODY CONTOURING DEVICES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 LASER & ENERGY BASED DEVICES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 COSMETIC IMPLANTS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 DERMAL FILLERS & NEUROMODULATORS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 MICRONEEDLING & CHEMICAL PEELS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
14.8 MICRODERMABRASION
14.8.1 MARKET OVERVIEW
14.8.2 MARKET SIZE & FORECAST
14.8.3 MARKET BY GEOGRAPHY
14.9 OTHERS
14.9.1 MARKET OVERVIEW
14.9.2 MARKET SIZE & FORECAST
14.9.3 MARKET BY GEOGRAPHY

15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 BODY CONTOURING & CELLULITE REDUCTION
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 SKIN TIGHTENING & RESURFACING
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 FACIAL AESTHETICS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
15.6 BREAST AUGMENTATION
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 MARKET BY GEOGRAPHY
15.7 OTHERS
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
15.7.3 MARKET BY GEOGRAPHY

16 END USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS & SKIN CLINICS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 MEDICAL SPAS & BEAUTY CENTERS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 HOMECARE
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PROCEDURE
18.3.1 MARKET SIZE & FORECAST
18.4 PRODUCT
18.4.1 MARKET SIZE & FORECAST
18.5 APPLICATION
18.5.1 MARKET SIZE & FORECAST
18.6 END USER
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 US: MARKET SIZE & FORECAST
18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PROCEDURE
19.3.1 MARKET SIZE & FORECAST
19.4 PRODUCT
19.4.1 MARKET SIZE & FORECAST
19.5 APPLICATION
19.5.1 MARKET SIZE & FORECAST
19.6 END USER
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 GERMANY: MARKET SIZE & FORECAST
19.7.2 UK: MARKET SIZE & FORECAST
19.7.3 ITALY: MARKET SIZE & FORECAST
19.7.4 SPAIN: MARKET SIZE & FORECAST
19.7.5 FRANCE: MARKET SIZE & FORECAST

20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PROCEDURE
20.3.1 MARKET SIZE & FORECAST
20.4 PRODUCT
20.4.1 MARKET SIZE & FORECAST
20.5 APPLICATION
20.5.1 MARKET SIZE & FORECAST
20.6 END USER
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 CHINA: MARKET SIZE & FORECAST
20.7.2 JAPAN: MARKET SIZE & FORECAST
20.7.3 INDIA: MARKET OVERVIEW
20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.7.5 AUSTRALIA: MARKET OVERVIEW

21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PROCEDURE
21.3.1 MARKET SIZE & FORECAST
21.4 PRODUCT
21.4.1 MARKET SIZE & FORECAST
21.5 APPLICATION
21.5.1 MARKET SIZE & FORECAST
21.6 END USER
21.6.1 MARKET SIZE & FORECAST
21.7 KEY COUNTRIES
21.7.1 BRAZIL: MARKET SIZE & FORECAST
21.7.2 MEXICO: MARKET SIZE & FORECAST
21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 PROCEDURE
22.3.1 MARKET SIZE & FORECAST
22.4 PRODUCT
22.4.1 MARKET SIZE & FORECAST
22.5 APPLICATION
22.5.1 MARKET SIZE & FORECAST
22.6 END USER
22.6.1 MARKET SIZE & FORECAST
22.7 KEY COUNTRIES
22.7.1 TURKEY: MARKET SIZE & FORECAST
22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 ABBVIE
23.2.2 BAUSCH HEALTH COMPANIES
23.2.3 CANDELA
23.2.4 CUTERA
23.2.5 CYNOSURE
23.2.6 EL.EN. S.P.A.
23.2.7 LUMENIS
23.2.8 MERZ PHARMA
23.2.9 SISRAM MEDICAL

24 KEY COMPANY PROFILES
24.1 ABBVIE (ALLERGAN)
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 BAUSCH HEALTH COMPANIES
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 CANDELA
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 CUTERA
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 CYNOSURE
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
24.6 EL.EN. S.P.A.
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.6.3 KEY STRATEGIES
24.6.4 KEY STRENGTHS
24.6.5 KEY OPPORTUNITIES
24.7 GALDERMA
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.7.3 KEY STRATEGIES
24.7.4 KEY STRENGTHS
24.7.5 KEY OPPORTUNITIES
24.8 JOHNSON & JOHNSON
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.8.3 KEY STRATEGIES
24.8.4 KEY STRENGTHS
24.8.5 KEY OPPORTUNITIES
24.9 LUMENIS
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.9.3 KEY STRATEGIES
24.9.4 KEY STRENGTHS
24.9.5 KEY OPPORTUNITIES
24.10 MERZ PHARMA
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.10.3 KEY STRATEGIES
24.10.4 KEY STRENGTHS
24.10.5 KEY OPPORTUNITIES
24.11 SIENTRA
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.11.3 KEY STRATEGIES
24.11.4 KEY STRENGTHS
24.11.5 KEY OPPORTUNITIES
24.12 SINCLAIR
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.12.3 KEY STRATEGIES
24.12.4 KEY STRENGTHS
24.12.5 KEY OPPORTUNITIES
24.13 SISRAM MEDICAL
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.13.3 KEY STRATEGIES
24.13.4 KEY STRENGTHS
24.13.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS
25.1 AEROLASE
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 AESTHETICS BIOMEDICAL
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 ASCLEPION LASER TECHNOLOGIES
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 ASTANZA LASER
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 BEIJING SANHE BEAUTY S & T CO.
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 BEIJING ADSS DEVELOPMENT
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 BIOLITEC
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 BIOTEC ITALIA
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 BISON MEDICAL
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 BLUECORE COMPANY
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 BRERA MEDICAL TECHNOLOGIES S.R.L.
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 BTL AESTHETICS
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 CARTESSA AESTHETICS
25.13.1 BUSINESS OVERVIEW
25.13.2 24.15.2 PRODUCT OFFERINGS
25.14 DOMINION AESTHETIC TECHNOLOGIES
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 ERCHONIA
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 ENDYMED
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 F CARE SYSTEMS
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 GIGAALASER
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 GSD - GLOBAL SKIN DERMATOLOGIST
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 INMODE AESTHETIC SOLUTIONS
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 LEAFLIFE TECHNOLOGY
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 LINLINE MEDICAL SYSTEMS
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 LUTRONIC
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 LYNTON LASERS
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 MEDART APS
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 MICROAIRE SURGICAL INSTRUMENTS
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS
25.27 MEDYTOX
25.27.1 BUSINESS OVERVIEW
25.27.2 PRODUCT OFFERINGS
25.28 MEYER-HAAKE
25.28.1 BUSINESS OVERVIEW
25.28.2 PRODUCT OFFERINGS
25.29 PHOTOMEDEX
25.29.1 BUSINESS OVERVIEW
25.29.2 PRODUCT OFFERINGS
25.30 REVANCE AESTHETICS
25.30.1 BUSINESS OVERVIEW
25.30.2 PRODUCT OFFERINGS
25.31 SCITON
25.31.1 BUSINESS OVERVIEW
25.31.2 PRODUCT OFFERINGS
25.32 THERMIGEN
25.32.1 BUSINESS OVERVIEW
25.32.2 PRODUCT OFFERINGS
25.33 VENUS CONCEPT
25.33.1 BUSINESS OVERVIEW
25.33.2 PRODUCT OFFERINGS
25.34 WAVEMED
25.34.1 BUSINESS OVERVIEW
25.34.2 PRODUCT OFFERINGS
25.35 ZIMMER MEDIZINSYSTEME
25.35.1 BUSINESS OVERVIEW
25.35.2 PRODUCT OFFERINGS

26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY PROCEDURE
27.3 MARKET BY PRODUCTS
27.4 MARKET BY APPLICATIONS
27.5 MARKET BY END USER
27.6 MARKET BY PROCEDURE: BY REGION
27.6.1 NORTH AMERICA: MARKET BY PROCEDURE
27.6.2 EUROPE: MARKET BY PROCEDURE
27.6.3 APAC: MARKET BY PROCEDURE
27.6.4 LATIN AMERICA: MARKET BY PROCEDURE
27.6.5 MIDDLE EAST & AFRICA: MARKET BY PROCEDURE
27.7 MARKET BY PRODUCTS: BY REGION
27.7.1 NORTH AMERICA: MARKET BY PRODUCT
27.7.2 EUROPE: MARKET BY PRODUCT
27.7.3 APAC: MARKET BY PRODUCT
27.7.4 LATIN AMERICA: MARKET BY PRODUCT
27.7.5 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
27.8 MARKET BY APPLICATION: BY REGION
27.8.1 NORTH AMERICA: MARKET BY APPLICATION
27.8.2 EUROPE: MARKET BY APPLICATION
27.8.3 APAC: MARKET BY APPLICATION
27.8.4 LATIN AMERICA: MARKET BY APPLICATION
27.8.5 MIDDLE EAST & AFRICA: MARKET BY APPLICATION
27.9 MARKET BY END USER: BY REGION
27.9.1 NORTH AMERICA: MARKET BY END USER
27.9.2 EUROPE: MARKET BY END USER
27.9.3 APAC: MARKET BY END USER
27.9.4 LATIN AMERICA: MARKET BY END USER
27.9.5 MIDDLE EAST & AFRICA: MARKET BY END USER

28 APPENDIX
28.1 ABBREVIATIONS

EXHIBIT 1 SEGMENTATION OF GLOBAL MEDICAL AESTHETICS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 TYPES OF MINIMALLY INVASIVE & NON-INVASIVE COSMETIC SURGERIES
EXHIBIT 4 TOP AESTHETIC TREATMENTS WORLDWIDE 2020
EXHIBIT 5 TOP AESTHETIC TREATMENTS WORLDWIDE 2019
EXHIBIT 6 DEMAND FOR MINIMALLY INVASIVE PROCEDURES 2020
EXHIBIT 7 TOP REASONS FOR GROWING POPULARITY OF MEDICAL AESTHETIC TOURISM
EXHIBIT 8 GLOBAL MEDICAL AESTHETICS MARKET SEGMENTATIONS
EXHIBIT 9 IMPACT OF APPLICATION OF PLATELET-RICH PLASMA (PRP) IN MEDICAL AESTHETICS
EXHIBIT 10 IMPACT OF ADVANCES IN MEDICAL AESTHETICS
EXHIBIT 11 IMPACT OF LAUNCH OF NEW MEDICAL AESTHETIC TREATMENTS
EXHIBIT 12 IMPACT OF BETTER ACCESS TO COSMETIC SURGERIES THROUGH MEDICAL TOURISM
EXHIBIT 13 EVOLUTION OF MEDICAL TOURISM
EXHIBIT 14 TOP MEDICAL TOURISM DESTINATIONS WITH TOP MEDICAL SERVICES
EXHIBIT 15 IMPACT OF INCREASING EXPENDITURE ON MEDICAL AESTHETIC SOLUTIONS
EXHIBIT 16 IMPACT OF RISE IN DEMAND FOR MINIMALLY INVASIVE & NON-INVASIVE SURGERIES
EXHIBIT 17 MINIMALLY INVASIVE & NON-INVASIVE AESTHETIC PROCEDURES PERFORMED IN 2020
EXHIBIT 18 IMPACT OF AGING DEMOGRAPHICS & INCREASING FOCUS ON IMPROVING APPEARANCE
EXHIBIT 19 PERCENTAGE SHARE OF PEOPLE AGED 65 YEARS & ABOVE 2019 & 2060
EXHIBIT 20 COSMETIC SURGERIES: TOP FIVE COUNTRIES
EXHIBIT 21 IMPACT OF SIDE EFFECTS ASSOCIATED WITH MEDICAL AESTHETIC TREATMENTS
EXHIBIT 22 IMPACT OF HIGH COSTS ASSOCIATED WITH MEDICAL AESTHETIC TREATMENTS
EXHIBIT 23 MAJOR COST BURDEN OF COSMETIC SURGERIES
EXHIBIT 24 GLOBAL MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 25 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY
EXHIBIT 26 GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE
EXHIBIT 27 GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCT
EXHIBIT 28 GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATION
EXHIBIT 29 GLOBAL MEDICAL AESTHETICS MARKET BY END USER
EXHIBIT 30 FIVE FORCES ANALYSIS 2021
EXHIBIT 31 INCREMENTAL GROWTH BY PROCEDURES 2021 & 2027
EXHIBIT 32 GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE 2022–2027
EXHIBIT 33 GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE: INCREMENTAL GROWTH
EXHIBIT 34 GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE: ABSOLUTE GROWTH
EXHIBIT 35 MAJOR MINIMALLY INVASIVE COSMETIC PROCEDURES
EXHIBIT 36 POPULAR MINIMALLY INVASIVE AESTHETIC PROCEDURES WORLDWIDE
EXHIBIT 37 GLOBAL MINIMALLY INVASIVE MEDICAL AESTHETICS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL MINIMALLY INVASIVE MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 39 COSMETIC SURGERIES: TOP FIVE COUNTRIES
EXHIBIT 40 GLOBAL NON-INVASIVE MEDICAL AESTHETICS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL NON-INVASIVE MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 43 GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCTS 2022–2027
EXHIBIT 44 GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 45 GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING DEVICES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 LIPOSUCTION COSMETIC SURGERIES 2017–2020 (THE US)
EXHIBIT 48 BODY CONTOURING AFTER MASSIVE WEIGHT LOSS PROCEDURES IN AMERICA 2020
EXHIBIT 49 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING DEVICES 2021–2027 ($ BILLION)
EXHIBIT 50 APPLICATIONS OF LASER & ENERGY-BASED DEVICES IN MEDICAL AESTHETICS
EXHIBIT 51 GLOBAL MEDICAL AESTHETICS MARKET BY LASER & ENERGY-BASED DEVICES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL MEDICAL AESTHETICS MARKET BY LASER & ENERGY-BASED DEVICES 2021–2027 ($ BILLION)
EXHIBIT 53 NUMBER OF BREAST AUGMENTATION PROCEDURES WORLDWIDE 2016, 2019, & 2020
EXHIBIT 54 PERCENTAGE SHARE OF BREAST AUGMENTATION AMONG DIFFERENT AGE GROUPS AND % CHANGE IN US 2019 & 2020
EXHIBIT 55 GLOBAL MEDICAL AESTHETICS MARKET BY COSMETIC IMPLANTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL MEDICAL AESTHETICS MARKET BY COSMETIC IMPLANTS 2021–2027 ($ BILLION)
EXHIBIT 57 GROWTH DRIVERS FOR DERMAL FILLERS
EXHIBIT 58 GLOBAL MEDICAL AESTHETICS MARKET BY DERMA FILLERS & NEUROMODULATORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 59 DERMAL FILLERS PROCEDURE BY AGE GROUP 2019 & 2020
EXHIBIT 60 VOLUME OF BOTULINUM TOXIN PROCEDURES BY AGE GROUP 2020
EXHIBIT 61 BOTOX: ANNUAL REVENUE 2015-2020
EXHIBIT 62 GLOBAL DERMAL FILLERS & NEUROMODULATORS MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 63 GLOBAL MEDICAL AESTHETICS MARKET BY MICRONEEDLING & CHEMICAL PEELS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL MEDICAL AESTHETICS MARKET BY MICRONEEDLING & CHEMICAL PEELS 2021–2027 ($ BILLION)
EXHIBIT 65 MICRODERMABRASION COSMETIC SURGERIES 2017-2020
EXHIBIT 66 GLOBAL MEDICAL AESTHETICS MARKET BY MICRODERMABRASION: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL MEDICAL AESTHETICS MARKET BY MICRODERMABRASION 2021–2027 ($ BILLION)
EXHIBIT 68 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER PRODUCTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION)
EXHIBIT 70 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 71 GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATION
EXHIBIT 72 GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 73 GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 74 BODY CONTOURING AFTER MASSIVE WEIGHT LOSS PROCEDURE DURING 2019–2020
EXHIBIT 75 BODY CONTOURING PROCEDURE STATISTICS
EXHIBIT 76 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING & CELLULITE REDUCTION: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING & CELLULITE REDUCTION 2021–2027 ($ BILLION)
EXHIBIT 78 PERCENTAGE OF PLASTIC SURGEONS PERFORMING FACIAL REJUVENATION AND NON-SURGICAL SKIN TIGHTENING PROCEDURES 2020
EXHIBIT 79 GLOBAL MEDICAL AESTHETICS MARKET BY SKIN TIGHTENING & RESURFACING: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 80 GLOBAL MEDICAL AESTHETICS MARKET BY SKIN TIGHTENING & RESURFACING 2021–2027 ($ BILLION)
EXHIBIT 81 BOTULINUM TOXIN: NON-SURGICAL PROCEDURES PERFORMED WORLDWIDE 2020
EXHIBIT 82 GLOBAL MEDICAL AESTHETICS MARKET BY FACIAL AESTHETICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 83 GLOBAL MEDICAL AESTHETICS MARKET BY FACIAL AESTHETICS 2021–2027 ($ BILLION)
EXHIBIT 84 GLOBAL MEDICAL AESTHETICS MARKET BY BREAST AUGMENTATION: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 85 NUMBER OF BREAST AUGMENTATION PROCEDURES 2020
EXHIBIT 86 GLOBAL BREAST AUGMENTATION MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 87 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER APPLICATIONS 2021–2027 ($ BILLION)
EXHIBIT 88 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER APPLICATIONS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 89 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 90 GLOBAL MEDICAL AESTHETICS MARKET BY END USER
EXHIBIT 91 GLOBAL MEDICAL AESTHETICS MARKET BY END USER: INCREMENTAL GROWTH
EXHIBIT 92 GLOBAL MEDICAL AESTHETICS MARKET BY END USER: ABSOLUTE GROWTH
EXHIBIT 93 COSMETIC & RECONSTRUCTIVE DEMOGRAPHICS DONE IN HOSPITALS 2020
EXHIBIT 94 GLOBAL MEDICAL AESTHETICS MARKET BY HOSPITALS & SKIN CLINICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 95 GLOBAL MEDICAL AESTHETICS MARKET BY HOSPITALS & SKIN CLINICS 2021–2027 ($ BILLION)
EXHIBIT 96 MEDICAL AESTHETIC TREATMENTS DELIVERED IN MEDICAL SPAS & BEAUTY CENTRES
EXHIBIT 97 GLOBAL MEDICAL AESTHETICS MARKET BY MEDICAL SPAS & BEAUTY CENTERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 98 GLOBAL MEDICAL AESTHETICS MARKET BY MEDICAL SPAS & BEAUTY CENTERS 2021–2027 ($ BILLION)
EXHIBIT 99 GLOBAL MEDICAL AESTHETICS MARKET BY HOMECARE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 100 GLOBAL MEDICAL AESTHETICS MARKET BY HOMECARE 2021–2027 ($ BILLION)
EXHIBIT 102
EXHIBIT 103 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 104 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY
EXHIBIT 105 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 106 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 107 NORTH AMERICA MEDICAL AESTHETICS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 108 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 109 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 110 TOP SURGICAL COSMETIC PROCEDURES IN US (2020)
EXHIBIT 111 TOP SURGICAL PROCEDURES BY AGE 2020
EXHIBIT 112 US MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 113 CANADA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 114 EUROPE MEDICAL AESTHETICS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 115 EUROPE MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 116 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 117 GERMANY: COSMETIC SURGICAL PROCEDURE STATISTICS 2020
EXHIBIT 118 TYPE
EXHIBIT 119 GERMANY MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 120 UK: COSMETIC SURGERY STATISTICS 2019
EXHIBIT 121 UK MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 122 ITALY MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 123 SPAIN: MOST COMMON AESTHETIC PROCEDURES 2020
EXHIBIT 124 SPAIN: COSMETIC SURGERY COST SAVING (2020)
EXHIBIT 125 SPAIN MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 126 FRANCE MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 127 APAC MEDICAL AESTHETICS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 128 APAC MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 129 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 130 CHINA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 131 JAPAN: COSMETIC SURGERIES PERFORMED IN JAPAN 2019 & 2020.
EXHIBIT 132 JAPAN MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 133 INDIA: MEDICAL AESTHETIC/COSMETIC SURGERIES STATISTICS 2020
EXHIBIT 134 MEDICAL AESTHETICS MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 135 SOUTH KOREA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 136 AUSTRALIA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 137 MEDICAL AESTHETICS MARKET IN LATIN AMERICA: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 138 LATIN AMERICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 139 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 140 COSMETIC SURGICAL PROCEDURES IN BRAZIL IN 2019
EXHIBIT 141 BRAZIL MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 142 MEXICO MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 143 ARGENTINA: MEDICAL AESTHETIC/COSMETIC SURGERIES 2020 STATISTICS
EXHIBIT 144 MEDICAL AESTHETICS MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 145 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 146 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 147 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 148 TURKEY: COSMETIC SURGICAL PROCEDURES 2020
EXHIBIT 149 TURKEY MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 150 SAUDI ARABIA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 151 SOUTH AFRICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 152 MEDICAL AESTHETICS MARKET PURE MARKET PLAYERS & DIVERSIFIED COMPANIES
EXHIBIT 153 MEDICAL AESTHETICS MARKET PLAYERS WITH STRATEGIES, STRENGTHS DEVELOPMENT ACTIVITIES
EXHIBIT 154 MEDICAL AESTHETICS MARKET: COMPETITIVE LANDSCAPE

LIST OF TABLES


TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 GLOBAL MINIMALLY INVASIVE MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 4 GLOBAL MINIMALLY INVASIVE MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 5 GLOBAL NON-INVASIVE MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 6 GLOBAL NON-INVASIVE MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 7 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING DEVICES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 8 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING DEVICES 2021–2027 (%) (GEOGRAPHY)
TABLE 9 GLOBAL MEDICAL AESTHETICS MARKET BY LASER & ENERGY-BASED DEVICES 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 10 GLOBAL MEDICAL AESTHETICS MARKET BY LASER & ENERGY-BASED DEVICES 2021–2027 (%) (GEOGRAPHY)
TABLE 11 GLOBAL MEDICAL AESTHETICS MARKET BY COSMETIC IMPLANTS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 12 GLOBAL MEDICAL AESTHETICS MARKET BY COSMETIC IMPLANTS 2021–2027 (%) (GEOGRAPHY)
TABLE 13 GLOBAL DERMAL FILLERS & NEUROMODULATORS MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 14 GLOBAL DERMAL FILLERS & NEUROMODULATORS MEDICAL AESTHETICS MARKET 2021–2027 (%) (GEOGRAPHY)
TABLE 15 GLOBAL MEDICAL AESTHETICS MARKET BY MICRONEEDLING & CHEMICAL PEELS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 16 GLOBAL MEDICAL AESTHETICS MARKET BY MICRONEEDLING & CHEMICAL PEELS 2021–2027 (%) (GEOGRAPHY)
TABLE 17 GLOBAL MEDICAL AESTHETICS MARKET BY MICRODERMABRASION 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 18 GLOBAL MEDICAL AESTHETICS MARKET BY MICRODERMABRASION 2021–2027 (%) (GEOGRAPHY)
TABLE 19 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER PRODUCTS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 20 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER PRODUCTS 2021–2027 (%) (GEOGRAPHY)
TABLE 21 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING & CELLULITE REDUCTION 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 22 GLOBAL MEDICAL AESTHETICS MARKET BY BODY CONTOURING & CELLULITE REDUCTION 2021–2027 (%) (GEOGRAPHY)
TABLE 23 GLOBAL MEDICAL AESTHETICS MARKET BY SKIN TIGHTENING & RESURFACING 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 24 GLOBAL MEDICAL AESTHETICS MARKET BY SKIN TIGHTENING & RESURFACING 2021–2027 (%) (GEOGRAPHY)
TABLE 25 GLOBAL MEDICAL AESTHETICS MARKET BY FACIAL AESTHETICS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 26 GLOBAL MEDICAL AESTHETICS MARKET BY FACIAL AESTHETICS 2021–2027 (%) (GEOGRAPHY)
TABLE 27 GLOBAL BREAST AUGMENTATION MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 28 GLOBAL BREAST AUGMENTATION MEDICAL AESTHETICS MARKET 2021–2027 (%) (GEOGRAPHY)
TABLE 29 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER APPLICATIONS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 30 GLOBAL MEDICAL AESTHETICS MARKET BY OTHER APPLICATIONS 2021–2027 (%) (GEOGRAPHY)
TABLE 31 GLOBAL MEDICAL AESTHETICS MARKET BY HOSPITALS & SKIN CLINICS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 32 GLOBAL MEDICAL AESTHETICS MARKET BY HOSPITALS & SKIN CLINICS 2021–2027 (%) (GEOGRAPHY)
TABLE 33 GLOBAL MEDICAL AESTHETICS MARKET BY MEDICAL SPAS & BEAUTY CENTERS 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 34 GLOBAL MEDICAL AESTHETICS MARKET BY MEDICAL SPAS & BEAUTY CENTERS 2021–2027 (%) (GEOGRAPHY)
TABLE 35 GLOBAL MEDICAL AESTHETICS MARKET BY HOMECARE 2021–2027 ($ BILLION) (GEOGRAPHY)
TABLE 36 GLOBAL MEDICAL AESTHETICS MARKET BY HOMECARE 2021–2027 (%) (GEOGRAPHY)
TABLE 37 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
TABLE 38 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 (%)
TABLE 39 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
TABLE 40 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 (%)
TABLE 41 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
TABLE 42 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 (%)
TABLE 43 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 ($ BILLION)
TABLE 44 NORTH AMERICA MEDICAL AESTHETICS MARKET 2021–2027 (%)
TABLE 45 EUROPE MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 46 EUROPE MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 47 EUROPE MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 48 EUROPE MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 (%)
TABLE 49 APPLICATION IN NORTH AMERICA 2021−2027 ($ BILLION)
TABLE 50 APPLICATION IN NORTH AMERICA 2021−2027 (%)
TABLE 51 END USER IN NORTH AMERICA 2021−2027 ($ BILLION)
TABLE 52 END USER IN NORTH AMERICA 2021−2027 (%)
TABLE 53 TOTAL COSMETIC SURGICAL PROCEDURE FOR FACE & HEAD 2020
TABLE 54 TOTAL COSMETIC SURGICAL PROCEDURE FOR BODY & EXTREMITIES 2020
TABLE 55 ITALY: TOTAL COSMETIC SURGICAL 2019 & 2020
TABLE 56 APAC MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 57 APAC MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 58 APAC MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 59 APAC MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 (%)
TABLE 60 APAC MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 61 APAC MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 (%)
TABLE 62 APAC MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 63 APAC MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 64 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 65 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 66 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 67 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 (%)
TABLE 68 LATIN AMERICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 69 LATIN AMERICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 (%)
TABLE 70 LATIN AMERICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 71 LATIN AMERICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 72 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 73 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 74 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 ($ BILLION)
TABLE 75 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PRODUCT 2021–2027 (%)
TABLE 76 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 77 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 (%)
TABLE 78 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 79 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 80 ABBVIE: MAJOR PRODUCT OFFERINGS
TABLE 81 BAUSCH HEALTH COMPANIES: MAJOR PRODUCT OFFERINGS
TABLE 82 CANDELA: MAJOR PRODUCT OFFERINGS
TABLE 83 CUTERA: MAJOR PRODUCT OFFERINGS
TABLE 84 CYNOSURE: MAJOR PRODUCT OFFERINGS
TABLE 85 EL.EN. S.P.A.: MAJOR PRODUCT OFFERINGS
TABLE 86 GALDERMA: MAJOR PRODUCT OFFERINGS
TABLE 87 JOHNSON & JOHNSON: MAJOR PRODUCT OFFERINGS
TABLE 88 LUMENIS: MAJOR PRODUCT OFFERINGS
TABLE 89 MERZ PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 90 SIENTRA: MAJOR PRODUCT OFFERINGS
TABLE 91 SINCLAIR: MAJOR PRODUCT OFFERINGS
TABLE 92 SISRAM MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 93 AEROLASE: MAJOR PRODUCT OFFERINGS
TABLE 94 AESTHETICS BIOMEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 95 ASCLEPION LASER TECHNOLOGIES GMBH: MAJOR PRODUCT OFFERINGS
TABLE 96 ASTANZA LASER: MAJOR PRODUCT OFFERINGS
TABLE 97 BEIJING SANHE BEAUTY S & T CO.: MAJOR PRODUCT OFFERINGS
TABLE 98 BEIJING ADSS DEVELOPMENT: MAJOR PRODUCT OFFERINGS
TABLE 99 BIOLITEC: MAJOR PRODUCT OFFERINGS
TABLE 100 BIOTEC ITALIA: MAJOR PRODUCT OFFERINGS
TABLE 101 BISON MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 102 BLUECORE COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 103 BRERA MEDICAL TECHNOLOGIES S.R.L.: MAJOR PRODUCT OFFERINGS
TABLE 104 BTL AESTHETICS: MAJOR PRODUCT OFFERINGS
TABLE 105 CARTESSA AESTHETICS: MAJOR PRODUCT OFFERINGS
TABLE 106 DOMINION AESTHETIC TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 107 ERCHONIA: MAJOR PRODUCT OFFERINGS
TABLE 108 ENDYMED: MAJOR PRODUCT OFFERINGS
TABLE 109 F CARE SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 110 GIGAALASER: MAJOR PRODUCT OFFERINGS
TABLE 111 GSD - GLOBAL SKIN DERMATOLOGIST: MAJOR PRODUCT OFFERINGS
TABLE 112 INMODE AESTHETIC SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 113 LEAFLIFE TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 114 LINLINE MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 115 LUTRONIC CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 116 LYNTON LASERS: MAJOR PRODUCT OFFERINGS
TABLE 117 MEDART APS: MAJOR PRODUCT OFFERINGS
TABLE 118 MICROAIRE SURGICAL INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 119 MEDYTOX: MAJOR PRODUCT OFFERINGS
TABLE 120 MEYER-HAAKE: MAJOR PRODUCT OFFERINGS
TABLE 121 PHOTOMEDEX: MAJOR PRODUCT OFFERINGS
TABLE 122 REVANCE AESTHETICS: MAJOR PRODUCT OFFERINGS
TABLE 123 SCITON: MAJOR PRODUCT OFFERINGS
TABLE 124 THERMIGEN: MAJOR PRODUCT OFFERINGS
TABLE 125 VENUS CONCEPT: MAJOR PRODUCT OFFERINGS
TABLE 126 WAVEMED: MAJOR PRODUCT OFFERINGS
TABLE 127 ZIMMER MEDIZINSYSTEME: MAJOR PRODUCT OFFERINGS
TABLE 128 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 129 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 130 GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 131 GLOBAL MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 132 GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 ($ BILLION)
TABLE 133 GLOBAL MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 (%)
TABLE 134 GLOBAL MEDICAL AESTHETICS MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 135 GLOBAL MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 136 GLOBAL MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 137 GLOBAL MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 138 NORTH AMERICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 139 NORTH AMERICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 140 EUROPE MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 141 EUROPE MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 142 APAC MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 143 APAC MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 144 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 145 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 146 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 ($ BILLION)
TABLE 147 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PROCEDURE 2021–2027 (%)
TABLE 148 NORTH AMERICA MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 ($ BILLION)
TABLE 149 NORTH AMERICA MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 (%)
TABLE 150 EUROPE MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 ($ BILLION)
TABLE 151 EUROPE MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 (%)
TABLE 152 APAC MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 ($ BILLION)
TABLE 153 APAC MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 (%)
TABLE 154 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 ($ BILLION)
TABLE 155 LATIN AMERICA MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 (%)
TABLE 156 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 ($ BILLION)
TABLE 157 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY PRODUCTS 2021–2027 (%)
TABLE 158 NORTH AMERICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 159 NORTH AMERICA MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 160 EUROPE MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 161 EUROPE MEDICAL AESTHETICS MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 162 APAC MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 163 APAC MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 (%)
TABLE 164 LATIN AMERICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 165 LATIN AMERICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 (%)
TABLE 166 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 ($ BILLION)
TABLE 167 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY APPLICATION 2021–2027 (%)
TABLE 168 NORTH AMERICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 169 NORTH AMERICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 170 EUROPE MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 171 EUROPE MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 172 APAC MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 173 APAC MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 174 LATIN AMERICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 175 LATIN AMERICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)
TABLE 176 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 177 MIDDLE EAST & AFRICA MEDICAL AESTHETICS MARKET BY END USER 2021–2027 (%)

 

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date